Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 03, 2013 07:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present at the Goldman Sachs Global Healthcare Conference

SALT LAKE CITY, June 3, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, president and CEO, is scheduled to present at the Goldman Sachs 34th Annual...
June 01, 2013 08:00 ET | Source: Myriad Genetics, Inc.

AstraZeneca Advances PARP Inhibitor Into Phase 3 Trial With BRACAnalysis(R)

SALT LAKE CITY, June 1, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that AstraZeneca will use Myriad's BRACAnalysis test as a companion diagnostic to stratify patients...
May 30, 2013 07:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present PROLARIS(R) Data at ASCO 2013, Continuing Its Commitment to Cancer Research

SALT LAKE CITY, May 30, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that Jack Cuzick, Ph.D., of Queen Mary College University of London, will present data from five...
May 14, 2013 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present at the Bank of America Merrill Lynch Health Care Conference

SALT LAKE CITY, May 14, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, president and CEO, is scheduled to present at the Bank Of America Merrill...
May 07, 2013 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Reports Third Quarter Fiscal Year 2013 Results

SALT LAKE CITY, May 7, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced results for its third fiscal quarter and nine months ended March 31, 2013. Revenue for the third...
May 02, 2013 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Announces 2013 Analyst and Investor Day

SALT LAKE CITY, May 2, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that its Analyst and Investor Day for research analysts and institutional investors will take place...
May 02, 2013 07:00 ET | Source: Myriad Genetics, Inc.

Myriad to Present New Molecular Data for Patients With Prostate Cancer at the American Urological Association 2013 Annual Meeting

SALT LAKE CITY, May 2, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today highlighted new clinical data on the PROLARIS 46-gene cell cycle progression (CCP) signature in patients with...
April 18, 2013 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Announce Third Fiscal Quarter 2013 Results on Tuesday, May 7, 2013

SALT LAKE CITY, April 18, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will issue financial results for the third fiscal quarter 2013 following the close of...
April 17, 2013 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Adopts RainDance's Thunderstorm Platform for Next-Generation Sequencing Based Hereditary Cancer Panel

SALT LAKE CITY and LEXINGTON, Mass., April 17, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) and RainDance Technologies, Inc. today announced that they have entered into a commercial...
March 26, 2013 16:05 ET | Source: Myriad Genetics, Inc.

Myriad and PharmaMar Announce First Commercial Partnership With Myriad's New HRD Test

SALT LAKE CITY, March 26, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it has signed an agreement with PharmaMar, a leader in the development of marine-derived...